APAC Anticoccidial Drugs Market Size (2024 - 2029)

Asia-Pacific Anticoccidial Drugs Market Analysis

The APAC Anticoccidial Drugs Market size is estimated at USD 390.12 million in 2024, and is expected to reach USD 495.29 million by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

The APAC Anticoccidial Drugs Market size is estimated at USD 390.12 million in 2024, and is expected to reach USD 495.29 million by 2029, growing at a CAGR of 4.89% during the forecast period (2024-2029).

Due to the COVID-19 outbreak, a short-term negative impact was seen on the market due to decreased visits to veterinary hospitals and clinics. Healthcare services were significantly reduced due to social distancing measures taken by governments across the globe. For instance, as per the data published by the National Institute of Health in March 2021, it was observed that pet adoption increased in Asian countries during the pandemic, and initial vaccinations on pets were done regularly. However, other than pets, the farm animal vaccination was not done at a given time due to the pandemic restrictions. Additionally, standard practices such as routine animal checkups, diagnoses, and surgeries were disrupted. These decreased services lowered the coccidiosis diagnosis. But, at the later stage of the pandemic, smart agriculture and livestock production systems with animal welfare aspects were adopted. For instance, according to an article published by Frontiers in Veterinary Science in January 2021, initiatives such as a national risk assessment, clear communication channels, contingency plans, a crisis response group, and support systems for animal care providers were taken by Australia for animal welfare. This initiative during the pandemic led to increased demand for diagnosing animal diseases, and market started to witnessed gradual growth.

Factors such as increasing incidence of coccidiosis and advancements in veterinary healthcare are expected to drive market growth over the forecast period. For instance, according to an article published by Veterinaria Digital S.A., in December 2021, humidity and temperature conditions in Southeast Asia are two critical factors for the development and survival of coccidia and its vector, the Alphitobius beetle. All of them promote high infectious pressure in indigenous chicken breeds. According to the above source, a prevalence of 65.83% and 68.5% of coccidia, respectively, was observed in Ben Tre and Hau Giang provinces. Such a high incidence of coccidiosis in the region is expected to increase the demand for anticoccidial drugs, thereby driving the market growth.

Moreover, Eimeria is a genus of apicomplexan parasites that includes various species capable of causing the disease coccidiosis in animals such as cattle, poultry, dogs, cats, and smaller ruminants, including sheep and goats. According to the research article published in August 2022, in Queensland, Australia, weaned cattle tend to be more affected in summer due to coccidiosis, possibly because of stress, and even if it can happen to a year-old cattle, clinical infection usually starts at 1-2 months of age because coccidiosis rarely manifests in the first three weeks of life. Thus, the burden of coccidiosis among the target animals of specific age demands the availability of the effective treatment which is expected to boosts the market growth over the forecast period.

However, the availability of alternative treatment options in the market is expected to hinder market growth over the forecast period.

Asia-Pacific Anticoccidial Drugs Industry Segmentation

As per the report's scope, coccidiosis is one of the most frequent and prevalent parasitic diseases among domesticated animals. Its symptoms include weight loss, mild intermittent to severe diarrhea, feces containing mucus or blood, dehydration, and decreased breeding. Any drug used to combat the progression of coccidiosis in birds or animals, both food-producing and non-food-producing, is termed an anticoccidial. 

The Asia-Pacific Anticoccidial Drugs Market is Segmented By Drug Type (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, and Others), Drug Action (Coccidiostatic and Coccidiocidal), Animal (Livestock Animals and Companion Animals ), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, and Others), and Geography (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific). The report offers the value (in USD) for the above segments.